Biogen Wins Ruling in Tecfidera IP Case; Shares Rise

(Reuters) Biogen Inc on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top multiple sclerosis pill, Tecfidera, pushing shares up more than 1 percent on a day when most U.S. stocks were down. The ruling came from the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board in Washington.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply